DKK4 gene amplification occurs in as many as 6% of metastatic prostate cancers, while homozygous deletion has also been observed in both primary (4–5.5%) and metastatic cases (1.6–3.6%) (Table 1). This evidence concerns the gene DKK4 and prostate cancer.